Huons Global Co., Ltd. (KOSDAQ:084110)

Market Cap	565.00B
Revenue (ttm)	825.44B
Net Income (ttm)	24.39B
Shares Out	12.20M
EPS (ttm)	1,999.54
PE Ratio	23.16
Forward PE	n/a
Dividend	680.00 (1.46%)
Ex-Dividend Date	Nov 24, 2025

Volume	44,487
Average Volume	45,087
Open	47,800
Previous Close	46,700
Day's Range	45,900 - 47,800
52-Week Range	31,500 - 65,900
Beta	1.09
RSI	36.74
Earnings Date	Feb 12, 2026

About Huons Global

Huons Global Co., Ltd. manufactures and sells pharmaceutical products for human health in South Korea and internationally. The company offers oral solid form products in the areas of circulatory system, metabolic, anti-pyretic analgesic anti-inflammatory, musculoskeletal system, digestive system, antihistamine, respiratory system, antibiotic, well-being, urogenital system, other chemotherapeutic, and others; and injections in the areas of anesthetic, antipyretic, analgesic, anti-inflammatory, skeletal muscle relaxant, antispasmodic, antihistami...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1965
• Employees: 118
• Stock Exchange: KOSDAQ
• Ticker Symbol: 084110

Financial Performance

In 2024, Huons Global's revenue was 813.46 billion, an increase of 7.26% compared to the previous year's 758.38 billion. Earnings were 25.79 billion, a decrease of -32.81%.